import{u as c,j as e,S as d,L as a}from"./index-CBy_8_rc.js";function m(){const t=c(),i={"@context":"https://schema.org","@type":"ProductGroup",name:"Patented NCD Treatments",description:"Advanced diabetes therapies, cardiovascular innovations, respiratory biologics for NCD management across Africa",brand:{"@type":"Brand",name:"Pacem Health"}},n=[{id:"advanced-diabetes",name:"Advanced Diabetes Therapies",products:["GLP-1 receptor agonists","SGLT-2 inhibitors","DPP-4 inhibitors","Novel insulin analogs","Combination therapies"],icon:"üíâ",description:"Next-generation glucose control medications"},{id:"cardiovascular-innovations",name:"Cardiovascular Innovations",products:["PCSK9 inhibitors","ARNI therapy","Novel anticoagulants (NOACs)","Antiplatelet agents","Heart failure medications"],icon:"‚ù§Ô∏è",description:"Advanced cardiac and lipid management"},{id:"respiratory-biologics",name:"Respiratory & Asthma Biologics",products:["Monoclonal antibody therapies","ICS/LABA combinations","LAMA/LABA combinations","Triple therapy inhalers","Severe asthma treatments","Long-acting bronchodilators","Short-acting bronchodilators"],icon:"ü´Å",description:"Innovative respiratory disease management"},{id:"renal-protection",name:"Renal Protection Therapies",products:["Diabetic kidney disease medications","CKD progression inhibitors","Phosphate binders","ESA biosimilars"],icon:"üî¨",description:"Chronic kidney disease management"},{id:"osteoporosis",name:"Osteoporosis & Bone Health",products:["Denosumab","Teriparatide","Romosozumab","Bisphosphonates (branded)","Combination therapies"],icon:"ü¶¥",description:"Advanced bone density management"},{id:"neurological",name:"Neurological Disorders",products:["Novel anticonvulsants","Parkinson's disease therapies","Multiple sclerosis treatments","Migraine prevention","Alzheimer's medications"],icon:"üß†",description:"Innovative neurological therapeutics"},{id:"obesity-metabolic",name:"Obesity & Metabolic Syndrome",products:["GLP-1 for weight management","Combination weight loss therapies","Metabolic syndrome treatments"],icon:"‚öñÔ∏è",description:"Weight management and metabolic health"},{id:"rheumatology",name:"Rheumatology & Autoimmune",products:["JAK inhibitors","IL-17 inhibitors","IL-23 inhibitors","TNF-alpha blockers","Biosimilar biologics"],icon:"ü§≤",description:"Advanced inflammatory disease management"}];return e.jsxs("div",{className:"flex flex-col bg-white min-h-screen",children:[e.jsx(d,{title:"Patented NCD Treatments | Advanced NCD Medications | Pacem Health",description:"Patented NCD treatments including advanced diabetes therapies, cardiovascular innovations, respiratory biologics. Next-generation NCD management for African healthcare.",keywords:["patented NCD treatments Africa","advanced diabetes therapies","cardiovascular innovations","respiratory biologics Africa","NCD medications","patented pharmaceuticals","advanced NCD treatments","branded NCD medications Africa"],structuredData:i}),e.jsx("section",{className:"bg-[#4B2991] text-white py-3",children:e.jsx("div",{className:"max-w-7xl mx-auto px-4 sm:px-6 lg:px-8",children:e.jsxs("div",{className:"flex items-center gap-2 text-sm",children:[e.jsx(a,{to:"/",className:"hover:underline",children:"Home"}),e.jsx("span",{children:"/"}),e.jsx(a,{to:"/products",className:"hover:underline",children:"Products"}),e.jsx("span",{children:"/"}),e.jsx(a,{to:"/products/categories/branded-patented-pharmaceuticals",className:"hover:underline",children:"Branded & Patented Pharmaceuticals"}),e.jsx("span",{children:"/"}),e.jsx("span",{children:"Patented NCD Treatments"})]})})}),e.jsx("section",{className:"bg-gradient-to-br from-[#2563EB] to-[#1E40AF] text-white py-12 md:py-16",children:e.jsx("div",{className:"max-w-7xl mx-auto px-4 sm:px-6 lg:px-8",children:e.jsxs("div",{className:"max-w-3xl",children:[e.jsx("h1",{className:"text-3xl md:text-4xl lg:text-5xl mb-4",children:"Patented NCD Treatments"}),e.jsx("p",{className:"text-base md:text-lg lg:text-xl text-white/90 mb-6",children:"Innovative pharmaceutical solutions for non-communicable diseases including advanced diabetes therapies, novel cardiovascular treatments, and cutting-edge respiratory medications. Our portfolio features breakthrough therapies from leading innovators designed to improve outcomes for Africa's growing NCD burden."})]})})}),e.jsx("section",{className:"py-12 md:py-16",children:e.jsxs("div",{className:"max-w-7xl mx-auto px-4 sm:px-6 lg:px-8",children:[e.jsxs("div",{className:"mb-8 md:mb-12",children:[e.jsx("h2",{className:"text-2xl md:text-3xl mb-3 md:mb-4",children:"Product Groups"}),e.jsx("p",{className:"text-gray-600",children:"Browse our complete portfolio of innovative NCD treatments"})]}),e.jsx("div",{className:"grid md:grid-cols-2 lg:grid-cols-3 gap-6",children:n.map(s=>e.jsxs("div",{className:"bg-white border-2 border-gray-200 rounded-xl p-6 hover:border-[#2563EB] hover:shadow-xl transition-all duration-300 group",children:[e.jsx("div",{className:"text-4xl mb-3 group-hover:scale-110 transition-transform duration-300",children:s.icon}),e.jsx("h3",{className:"text-xl mb-2 group-hover:text-[#2563EB] transition-colors",children:s.name}),e.jsx("p",{className:"text-sm text-gray-600 mb-4",children:s.description}),e.jsx("div",{className:"space-y-1 mb-4",children:s.products.map((r,l)=>e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] text-xs mt-1",children:"‚Ä¢"}),e.jsx("span",{className:"text-sm text-gray-700",children:r})]},l))}),e.jsx("button",{className:"w-full py-2 bg-[#2563EB] text-white rounded-lg hover:bg-[#1D4ED8] transition-colors",children:"View Details"})]},s.id))}),e.jsx("div",{className:"mt-12 text-center",children:e.jsx("button",{onClick:()=>t("/products/categories/branded-patented-pharmaceuticals"),className:"text-[#2563EB] hover:underline",children:"‚Üê Back to Branded & Patented Pharmaceuticals"})})]})}),e.jsx("section",{className:"py-12 md:py-16 bg-gray-50",children:e.jsxs("div",{className:"max-w-7xl mx-auto px-4 sm:px-6 lg:px-8",children:[e.jsxs("div",{className:"text-center mb-8 md:mb-12",children:[e.jsx("h2",{className:"text-2xl md:text-3xl mb-3 md:mb-4",children:"Addressing Africa's NCD Challenge"}),e.jsx("p",{className:"text-base md:text-lg text-gray-600 max-w-3xl mx-auto",children:"Non-communicable diseases are rising rapidly across Africa, requiring access to innovative treatments"})]}),e.jsxs("div",{className:"grid md:grid-cols-4 gap-6",children:[e.jsxs("div",{className:"bg-white p-6 rounded-xl text-center border-2 border-gray-200",children:[e.jsx("div",{className:"text-4xl mb-3 text-[#2563EB]",children:"463M"}),e.jsx("h4",{className:"text-base mb-2",style:{fontWeight:600},children:"Diabetes"}),e.jsx("p",{className:"text-sm text-gray-600",children:"Adults with diabetes in Africa by 2045 (projected)"})]}),e.jsxs("div",{className:"bg-white p-6 rounded-xl text-center border-2 border-gray-200",children:[e.jsx("div",{className:"text-4xl mb-3 text-[#2563EB]",children:"27M"}),e.jsx("h4",{className:"text-base mb-2",style:{fontWeight:600},children:"Cardiovascular"}),e.jsx("p",{className:"text-sm text-gray-600",children:"Deaths from CVD annually across the continent"})]}),e.jsxs("div",{className:"bg-white p-6 rounded-xl text-center border-2 border-gray-200",children:[e.jsx("div",{className:"text-4xl mb-3 text-[#2563EB]",children:"125M"}),e.jsx("h4",{className:"text-base mb-2",style:{fontWeight:600},children:"Hypertension"}),e.jsx("p",{className:"text-sm text-gray-600",children:"Adults living with high blood pressure"})]}),e.jsxs("div",{className:"bg-white p-6 rounded-xl text-center border-2 border-gray-200",children:[e.jsx("div",{className:"text-4xl mb-3 text-[#2563EB]",children:"71%"}),e.jsx("h4",{className:"text-base mb-2",style:{fontWeight:600},children:"NCD Burden"}),e.jsx("p",{className:"text-sm text-gray-600",children:"Projected increase in NCD burden by 2030"})]})]})]})}),e.jsx("section",{className:"py-16",children:e.jsxs("div",{className:"max-w-7xl mx-auto px-4 sm:px-6 lg:px-8",children:[e.jsxs("div",{className:"text-center mb-12",children:[e.jsx("h2",{className:"text-3xl mb-4",children:"Comprehensive NCD Management Support"}),e.jsx("p",{className:"text-lg text-gray-600 max-w-3xl mx-auto",children:"Beyond medications: integrated services for chronic disease programs"})]}),e.jsxs("div",{className:"grid md:grid-cols-3 gap-8",children:[e.jsxs("div",{className:"bg-[#EBF8FF] p-8 rounded-xl",children:[e.jsx("div",{className:"text-4xl mb-4",children:"üè•"}),e.jsx("h4",{className:"text-lg mb-3",style:{fontWeight:600},children:"NCD Clinic Setup"}),e.jsxs("ul",{className:"space-y-2 text-sm text-gray-700",children:[e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB]",children:"‚úì"}),e.jsx("span",{children:"Diabetes and hypertension clinic design"})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB]",children:"‚úì"}),e.jsx("span",{children:"Equipment and diagnostic tools"})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB]",children:"‚úì"}),e.jsx("span",{children:"Patient flow optimization"})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB]",children:"‚úì"}),e.jsx("span",{children:"Pharmacy integration and stock management"})]})]})]}),e.jsxs("div",{className:"bg-[#EBF8FF] p-8 rounded-xl",children:[e.jsx("div",{className:"text-4xl mb-4",children:"üìö"}),e.jsx("h4",{className:"text-lg mb-3",style:{fontWeight:600},children:"Clinical Training"}),e.jsxs("ul",{className:"space-y-2 text-sm text-gray-700",children:[e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB]",children:"‚úì"}),e.jsx("span",{children:"Evidence-based treatment guidelines"})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB]",children:"‚úì"}),e.jsx("span",{children:"Medication titration protocols"})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB]",children:"‚úì"}),e.jsx("span",{children:"Complication screening and management"})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB]",children:"‚úì"}),e.jsx("span",{children:"Patient counseling and education"})]})]})]}),e.jsxs("div",{className:"bg-[#EBF8FF] p-8 rounded-xl",children:[e.jsx("div",{className:"text-4xl mb-4",children:"üìä"}),e.jsx("h4",{className:"text-lg mb-3",style:{fontWeight:600},children:"Data & Monitoring"}),e.jsxs("ul",{className:"space-y-2 text-sm text-gray-700",children:[e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB]",children:"‚úì"}),e.jsx("span",{children:"NCD patient registries"})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB]",children:"‚úì"}),e.jsx("span",{children:"Treatment adherence tracking"})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB]",children:"‚úì"}),e.jsx("span",{children:"Outcome measurement and reporting"})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB]",children:"‚úì"}),e.jsx("span",{children:"Quality improvement initiatives"})]})]})]})]})]})}),e.jsx("section",{className:"py-16 bg-gray-50",children:e.jsxs("div",{className:"max-w-7xl mx-auto px-4 sm:px-6 lg:px-8",children:[e.jsxs("div",{className:"text-center mb-12",children:[e.jsx("h2",{className:"text-3xl mb-4",children:"Key Therapeutic Focus Areas"}),e.jsx("p",{className:"text-lg text-gray-600 max-w-3xl mx-auto",children:"Innovative therapies for Africa's priority NCD conditions"})]}),e.jsxs("div",{className:"grid md:grid-cols-2 gap-8",children:[e.jsxs("div",{className:"bg-white p-8 rounded-xl border-2 border-gray-200",children:[e.jsxs("div",{className:"flex items-start gap-4 mb-4",children:[e.jsx("div",{className:"text-4xl",children:"üíâ"}),e.jsxs("div",{children:[e.jsx("h4",{className:"text-xl mb-2",style:{fontWeight:600},children:"Diabetes Management"}),e.jsx("p",{className:"text-sm text-gray-600 mb-3",children:"Beyond traditional insulin: novel mechanisms for glucose control"})]})]}),e.jsxs("div",{className:"space-y-3 text-sm text-gray-700",children:[e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"GLP-1 Receptor Agonists:"})," Weekly injections for Type 2 diabetes with cardiovascular and renal benefits"]})]}),e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"SGLT-2 Inhibitors:"})," Oral medications reducing glucose, CV events, and kidney disease progression"]})]}),e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Novel Insulins:"})," Ultra-long-acting basal insulins and rapid-acting analogs"]})]}),e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Combination Therapies:"})," Fixed-dose combinations for simplified regimens"]})]})]})]}),e.jsxs("div",{className:"bg-white p-8 rounded-xl border-2 border-gray-200",children:[e.jsxs("div",{className:"flex items-start gap-4 mb-4",children:[e.jsx("div",{className:"text-4xl",children:"‚ù§Ô∏è"}),e.jsxs("div",{children:[e.jsx("h4",{className:"text-xl mb-2",style:{fontWeight:600},children:"Cardiovascular Innovation"}),e.jsx("p",{className:"text-sm text-gray-600 mb-3",children:"Advanced therapies for heart disease and stroke prevention"})]})]}),e.jsxs("div",{className:"space-y-3 text-sm text-gray-700",children:[e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"PCSK9 Inhibitors:"})," Monoclonal antibodies for aggressive LDL reduction in high-risk patients"]})]}),e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"ARNI Therapy:"})," Angiotensin receptor-neprilysin inhibition for heart failure"]})]}),e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Novel Anticoagulants:"})," Direct oral anticoagulants (DOACs) for stroke prevention"]})]}),e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Antiplatelet Agents:"})," Advanced P2Y12 inhibitors for acute coronary syndromes"]})]})]})]}),e.jsxs("div",{className:"bg-white p-8 rounded-xl border-2 border-gray-200",children:[e.jsxs("div",{className:"flex items-start gap-4 mb-4",children:[e.jsx("div",{className:"text-4xl",children:"ü´Å"}),e.jsxs("div",{children:[e.jsx("h4",{className:"text-xl mb-2",style:{fontWeight:600},children:"Respiratory Disease"}),e.jsx("p",{className:"text-sm text-gray-600 mb-3",children:"Biologics and advanced inhalers for asthma and COPD"})]})]}),e.jsxs("div",{className:"space-y-3 text-sm text-gray-700",children:[e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Monoclonal Antibodies:"})," Targeted biologics for severe eosinophilic asthma"]})]}),e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Triple Therapy:"})," Single-inhaler ICS/LAMA/LABA combinations for COPD"]})]}),e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Novel Inhalers:"})," Dry powder and soft mist delivery systems"]})]}),e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Exacerbation Prevention:"})," Long-term control medications"]})]})]})]}),e.jsxs("div",{className:"bg-white p-8 rounded-xl border-2 border-gray-200",children:[e.jsxs("div",{className:"flex items-start gap-4 mb-4",children:[e.jsx("div",{className:"text-4xl",children:"üß†"}),e.jsxs("div",{children:[e.jsx("h4",{className:"text-xl mb-2",style:{fontWeight:600},children:"Neurological Conditions"}),e.jsx("p",{className:"text-sm text-gray-600 mb-3",children:"Novel therapies for epilepsy, Parkinson's, and MS"})]})]}),e.jsxs("div",{className:"space-y-3 text-sm text-gray-700",children:[e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Novel Anticonvulsants:"})," New mechanisms for refractory epilepsy"]})]}),e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Parkinson's Therapies:"})," Extended-release formulations and adjunctive treatments"]})]}),e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"MS Treatments:"})," Oral and injectable disease-modifying therapies"]})]}),e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚Üí"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Migraine Prevention:"})," CGRP monoclonal antibodies"]})]})]})]})]})]})}),e.jsx("section",{className:"py-16",children:e.jsxs("div",{className:"max-w-7xl mx-auto px-4 sm:px-6 lg:px-8",children:[e.jsxs("div",{className:"text-center mb-12",children:[e.jsx("h2",{className:"text-3xl mb-4",children:"Improving Access to Innovative NCD Treatments"}),e.jsx("p",{className:"text-lg text-gray-600 max-w-3xl mx-auto",children:"Strategic programs to make patented medications affordable and accessible"})]}),e.jsxs("div",{className:"grid md:grid-cols-2 lg:grid-cols-4 gap-6",children:[e.jsxs("div",{className:"bg-[#EBF8FF] p-6 rounded-xl",children:[e.jsx("div",{className:"text-3xl mb-3",children:"üí∞"}),e.jsx("h4",{className:"text-base mb-3",style:{fontWeight:600},children:"Tiered Pricing"}),e.jsx("p",{className:"text-sm text-gray-600",children:"Country-specific pricing based on economic status and disease burden"})]}),e.jsxs("div",{className:"bg-[#EBF8FF] p-6 rounded-xl",children:[e.jsx("div",{className:"text-3xl mb-3",children:"ü§ù"}),e.jsx("h4",{className:"text-base mb-3",style:{fontWeight:600},children:"Patient Assistance"}),e.jsx("p",{className:"text-sm text-gray-600",children:"Manufacturer-sponsored programs for qualifying patients"})]}),e.jsxs("div",{className:"bg-[#EBF8FF] p-6 rounded-xl",children:[e.jsx("div",{className:"text-3xl mb-3",children:"üèõÔ∏è"}),e.jsx("h4",{className:"text-base mb-3",style:{fontWeight:600},children:"Government Programs"}),e.jsx("p",{className:"text-sm text-gray-600",children:"National health insurance integration and bulk procurement"})]}),e.jsxs("div",{className:"bg-[#EBF8FF] p-6 rounded-xl",children:[e.jsx("div",{className:"text-3xl mb-3",children:"üîÑ"}),e.jsx("h4",{className:"text-base mb-3",style:{fontWeight:600},children:"Biosimilar Transition"}),e.jsx("p",{className:"text-sm text-gray-600",children:"Access to biosimilar biologics as patents expire"})]})]})]})}),e.jsx("section",{className:"py-16 bg-gray-50",children:e.jsxs("div",{className:"max-w-7xl mx-auto px-4 sm:px-6 lg:px-8",children:[e.jsxs("div",{className:"text-center mb-12",children:[e.jsx("h2",{className:"text-3xl mb-4",children:"Clinical Evidence & Outcomes"}),e.jsx("p",{className:"text-lg text-gray-600 max-w-3xl mx-auto",children:"Supporting treatment decisions with robust clinical data"})]}),e.jsxs("div",{className:"grid md:grid-cols-3 gap-8",children:[e.jsxs("div",{className:"bg-white p-8 rounded-xl border-2 border-gray-200",children:[e.jsx("h4",{className:"text-lg mb-4",style:{fontWeight:600},children:"Cardiovascular Outcome Trials"}),e.jsx("p",{className:"text-sm text-gray-700 mb-4",children:"Major clinical trials demonstrating CV risk reduction:"}),e.jsxs("ul",{className:"text-sm text-gray-600 space-y-2",children:[e.jsx("li",{children:"‚Ä¢ SGLT-2 inhibitors: 35% reduction in HF hospitalizations"}),e.jsx("li",{children:"‚Ä¢ GLP-1 RAs: 26% reduction in CV death/MI/stroke"}),e.jsx("li",{children:"‚Ä¢ PCSK9 inhibitors: 15% reduction in major CV events"})]})]}),e.jsxs("div",{className:"bg-white p-8 rounded-xl border-2 border-gray-200",children:[e.jsx("h4",{className:"text-lg mb-4",style:{fontWeight:600},children:"Renal Protection Studies"}),e.jsx("p",{className:"text-sm text-gray-700 mb-4",children:"Evidence for kidney disease progression prevention:"}),e.jsxs("ul",{className:"text-sm text-gray-600 space-y-2",children:[e.jsx("li",{children:"‚Ä¢ SGLT-2i: 39% reduction in CKD progression"}),e.jsx("li",{children:"‚Ä¢ GLP-1 RA: 22% reduction in kidney outcomes"}),e.jsx("li",{children:"‚Ä¢ Finerenone: 18% reduction in CKD composite"})]})]}),e.jsxs("div",{className:"bg-white p-8 rounded-xl border-2 border-gray-200",children:[e.jsx("h4",{className:"text-lg mb-4",style:{fontWeight:600},children:"Quality of Life Improvements"}),e.jsx("p",{className:"text-sm text-gray-700 mb-4",children:"Patient-reported outcomes and functional benefits:"}),e.jsxs("ul",{className:"text-sm text-gray-600 space-y-2",children:[e.jsx("li",{children:"‚Ä¢ Biologics: Significant asthma control improvement"}),e.jsx("li",{children:"‚Ä¢ Novel MS therapies: Reduced relapse rates"}),e.jsx("li",{children:"‚Ä¢ ARNI therapy: Improved heart failure symptoms"})]})]})]})]})}),e.jsx("section",{className:"py-16",children:e.jsxs("div",{className:"max-w-7xl mx-auto px-4 sm:px-6 lg:px-8",children:[e.jsx("div",{className:"text-center mb-12",children:e.jsx("h2",{className:"text-3xl mb-4",children:"Regulatory Excellence & Quality Assurance"})}),e.jsxs("div",{className:"grid md:grid-cols-2 gap-8",children:[e.jsxs("div",{className:"bg-gray-50 p-8 rounded-xl",children:[e.jsx("h4",{className:"text-xl mb-4",style:{fontWeight:600},children:"Stringent Regulatory Standards"}),e.jsxs("ul",{className:"space-y-3 text-gray-700",children:[e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚úì"}),e.jsxs("span",{children:[e.jsx("strong",{children:"FDA/EMA Approval:"})," All products approved by stringent regulatory authorities"]})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚úì"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Phase III Trials:"})," Comprehensive efficacy and safety data"]})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚úì"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Post-Marketing Surveillance:"})," Ongoing real-world safety monitoring"]})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚úì"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Label Updates:"})," Regular safety information updates"]})]})]})]}),e.jsxs("div",{className:"bg-gray-50 p-8 rounded-xl",children:[e.jsx("h4",{className:"text-xl mb-4",style:{fontWeight:600},children:"Distribution & Handling"}),e.jsxs("ul",{className:"space-y-3 text-gray-700",children:[e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚úì"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Temperature Control:"})," Specialized storage for biologics and sensitive medications"]})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚úì"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Authentication:"})," Serialization and anti-counterfeiting measures"]})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚úì"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Expiry Management:"})," Real-time inventory and FEFO protocols"]})]}),e.jsxs("li",{className:"flex items-start gap-2",children:[e.jsx("span",{className:"text-[#2563EB] mt-1",children:"‚úì"}),e.jsxs("span",{children:[e.jsx("strong",{children:"Provider Training:"})," Proper storage, handling, and administration"]})]})]})]})]})]})}),e.jsx("section",{className:"py-16 bg-gray-50",children:e.jsx("div",{className:"max-w-7xl mx-auto px-4 sm:px-6 lg:px-8",children:e.jsxs("div",{className:"grid md:grid-cols-4 gap-8",children:[e.jsxs("div",{className:"text-center",children:[e.jsx("div",{className:"text-4xl mb-2 text-[#2563EB]",children:"8"}),e.jsx("div",{className:"text-gray-600",children:"Therapeutic Areas"})]}),e.jsxs("div",{className:"text-center",children:[e.jsx("div",{className:"text-4xl mb-2 text-[#2563EB]",children:"40+"}),e.jsx("div",{className:"text-gray-600",children:"Innovative Medications"})]}),e.jsxs("div",{className:"text-center",children:[e.jsx("div",{className:"text-4xl mb-2 text-[#2563EB]",children:"100%"}),e.jsx("div",{className:"text-gray-600",children:"FDA/EMA Approved"})]}),e.jsxs("div",{className:"text-center",children:[e.jsx("div",{className:"text-4xl mb-2 text-[#2563EB]",children:"20+"}),e.jsx("div",{className:"text-gray-600",children:"Countries Served"})]})]})})})]})}export{m as default};
